CN Stock MarketDetailed Quotes

002940 Zhejiang Anglikang Pharmaceutical

Watchlist
  • 14.03
  • +0.04+0.29%
Market Closed Oct 18 15:00 CST
2.83BMarket Cap27.67P/E (TTM)

Zhejiang Anglikang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
0.49%847.41M
-3.89%407.99M
3.66%1.63B
11.65%1.19B
19.82%843.29M
25.52%424.51M
13.62%1.57B
7.72%1.06B
11.05%703.78M
6.06%338.21M
Operating revenue
0.49%847.41M
-3.89%407.99M
3.66%1.63B
11.65%1.19B
19.82%843.29M
25.52%424.51M
13.62%1.57B
7.72%1.06B
11.05%703.78M
6.06%338.21M
Other operating revenue
683.42%16.06M
----
-34.49%5.3M
----
-65.26%2.05M
----
47.68%8.09M
----
94.69%5.9M
----
Total operating cost
-1.99%720.42M
-5.58%364.38M
2.08%1.45B
12.18%1.06B
18.81%735.06M
31.82%385.93M
17.97%1.42B
9.77%947.92M
12.66%618.69M
4.12%292.78M
Operating cost
10.31%483.94M
6.70%245.86M
34.29%900.51M
50.76%647.1M
54.94%438.7M
74.38%230.42M
37.48%670.55M
21.91%429.23M
43.30%283.14M
20.38%132.13M
Operating tax surcharges
-11.31%7.45M
-10.36%3.94M
13.46%17.22M
14.17%11.87M
29.55%8.4M
47.64%4.39M
0.76%15.18M
-6.42%10.39M
-9.52%6.49M
-32.69%2.97M
Operating expense
-54.23%88.53M
-57.06%48.27M
-47.59%293.02M
-39.15%244.74M
-26.72%193.44M
-15.66%112.41M
-8.32%559.08M
-8.48%402.22M
-12.55%263.99M
-7.48%133.29M
Administration expense
-0.19%45.01M
6.82%21.03M
41.97%103.03M
40.19%69.14M
39.86%45.09M
44.44%19.68M
18.38%72.57M
11.45%49.32M
4.12%32.24M
-21.43%13.63M
Financial expense
-34.30%-6.41M
-119.56%-3.79M
19.52%-9.67M
17.66%-8.01M
30.04%-4.77M
56.54%-1.73M
50.93%-12.01M
50.90%-9.73M
39.72%-6.83M
30.66%-3.98M
-Interest expense (Financial expense)
58.59%9.74M
116.96%4.76M
121.51%14.17M
152.21%10.25M
183.55%6.14M
605.76%2.19M
1,638.59%6.39M
1,120.03%4.07M
765.50%2.17M
172.20%310.84K
-Interest Income (Financial expense)
-17.73%-11.47M
-37.87%-5.77M
-25.27%-21.95M
-24.07%-15.4M
-13.58%-9.74M
4.72%-4.18M
32.04%-17.52M
39.46%-12.41M
28.06%-8.58M
25.20%-4.39M
Research and development
88.02%101.9M
136.44%49.09M
27.30%143.37M
48.23%98.55M
36.66%54.2M
40.94%20.76M
114.30%112.62M
82.54%66.48M
73.14%39.66M
29.84%14.73M
Credit Impairment Loss
-96.83%67.18K
94.29%2.62M
47.84%1.4M
29.73%4.5M
20.26%2.12M
-45.63%1.35M
135.67%944.94K
18.02%3.47M
-42.10%1.76M
-12.43%2.48M
Asset Impairment Loss
-139.44%-592K
-189.50%-720.99K
-115.31%-13.98M
67.45%-1.82M
146.31%1.5M
--805.53K
-2,387.37%-6.49M
-465.16%-5.59M
-316.30%-3.24M
----
Other net revenue
-68.67%9.48M
-51.29%9.64M
1,863.39%33.3M
198.94%30.91M
246.58%30.27M
509.35%19.79M
54.92%-1.89M
332.08%10.34M
162.68%8.73M
9.89%3.25M
Invest income
-232.04%-2.22M
-58.40%-2.21M
42.49%-1.7M
-97.08%218.71K
-74.43%1.68M
-51.37%-1.39M
67.24%-2.96M
151.85%7.5M
216.61%6.56M
71.89%-920.11K
-Including: Investment income associates
-1,088.72%-4.08M
-131.85%-3.53M
45.11%-3.3M
-125.47%-1.7M
-105.45%-343K
-24.09%-1.52M
62.04%-6.01M
193.21%6.66M
210.42%6.3M
62.42%-1.23M
Asset deal income
-597.10%-1.45K
--9.47K
-1,858.24%-37.66K
---11.96K
---207.57
----
-154.71%-1.92K
----
----
----
Other revenue
-51.04%12.22M
-47.79%9.94M
618.83%47.62M
464.41%28.03M
584.03%24.97M
1,028.90%19.03M
-14.72%6.62M
-10.35%4.97M
-17.11%3.65M
-5.67%1.69M
Operating profit
-1.46%136.48M
-8.77%53.25M
42.49%211.68M
23.08%154.51M
47.61%138.5M
19.89%58.37M
-14.71%148.56M
5.58%125.54M
6.77%93.83M
19.78%48.68M
Add:Non operating Income
-49.27%162.49K
483.98%29.45K
-69.68%199.61K
28.72%576.92K
-25.58%320.28K
-36.34%5.04K
190.34%658.29K
125.98%448.19K
132.22%430.38K
-95.26%7.92K
Less:Non operating expense
-25.57%238.74K
342.68%248.69K
106.07%4.68M
57.49%3.27M
10.15%320.76K
493.75%56.18K
29.77%2.27M
39.47%2.08M
-52.69%291.2K
-94.06%9.46K
Total profit
-1.52%136.4M
-9.06%53.03M
41.00%207.2M
22.52%151.82M
47.39%138.5M
19.79%58.31M
-14.89%146.94M
5.35%123.91M
7.46%93.97M
19.76%48.68M
Less:Income tax cost
7.35%11.95M
-17.21%5.62M
61.35%24.13M
4.39%10.93M
43.67%11.14M
2.81%6.79M
-52.25%14.96M
-59.43%10.47M
-33.10%7.75M
62.15%6.6M
Net profit
-2.29%124.45M
-7.99%47.41M
38.70%183.06M
24.20%140.89M
47.73%127.37M
22.46%51.53M
-6.61%131.99M
23.56%113.44M
13.65%86.22M
15.04%42.08M
Net profit from continuing operation
-2.29%124.45M
-7.99%47.41M
38.70%183.06M
24.20%140.89M
47.73%127.37M
22.46%51.53M
-6.61%131.99M
23.56%113.44M
13.65%86.22M
15.04%42.08M
Less:Minority Profit
143.53%56.35M
330.60%19.19M
852.70%44.69M
502.03%31.1M
225.27%23.14M
49.01%4.46M
-78.16%4.69M
-68.92%5.17M
-30.81%7.11M
-21.16%2.99M
Net profit of parent company owners
-34.66%68.1M
-40.05%28.22M
8.70%138.37M
1.40%109.79M
31.76%104.23M
20.43%47.07M
6.22%127.3M
44.00%108.28M
20.62%79.1M
19.23%39.09M
Earning per share
Basic earning per share
-34.62%0.34
-39.13%0.14
7.81%0.69
0.00%0.54
30.00%0.52
-20.69%0.23
-26.44%0.64
-30.77%0.54
-41.18%0.4
-14.71%0.29
Diluted earning per share
-34.62%0.34
-39.13%0.14
7.81%0.69
0.00%0.54
30.00%0.52
-20.69%0.23
-26.44%0.64
-30.77%0.54
-41.18%0.4
-14.71%0.29
Other composite income
Total composite income
-2.29%124.45M
-7.99%47.41M
38.70%183.06M
24.20%140.89M
47.73%127.37M
22.46%51.53M
-6.61%131.99M
23.56%113.44M
13.65%86.22M
15.04%42.08M
Total composite income of parent company owners
-34.66%68.1M
-40.05%28.22M
8.70%138.37M
1.40%109.79M
31.76%104.23M
20.43%47.07M
6.22%127.3M
44.00%108.28M
20.62%79.1M
19.23%39.09M
Total composite income of minority owners
143.53%56.35M
330.60%19.19M
852.70%44.69M
502.03%31.1M
225.27%23.14M
49.01%4.46M
-78.16%4.69M
-68.92%5.17M
-30.81%7.11M
-21.16%2.99M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 0.49%847.41M-3.89%407.99M3.66%1.63B11.65%1.19B19.82%843.29M25.52%424.51M13.62%1.57B7.72%1.06B11.05%703.78M6.06%338.21M
Operating revenue 0.49%847.41M-3.89%407.99M3.66%1.63B11.65%1.19B19.82%843.29M25.52%424.51M13.62%1.57B7.72%1.06B11.05%703.78M6.06%338.21M
Other operating revenue 683.42%16.06M-----34.49%5.3M-----65.26%2.05M----47.68%8.09M----94.69%5.9M----
Total operating cost -1.99%720.42M-5.58%364.38M2.08%1.45B12.18%1.06B18.81%735.06M31.82%385.93M17.97%1.42B9.77%947.92M12.66%618.69M4.12%292.78M
Operating cost 10.31%483.94M6.70%245.86M34.29%900.51M50.76%647.1M54.94%438.7M74.38%230.42M37.48%670.55M21.91%429.23M43.30%283.14M20.38%132.13M
Operating tax surcharges -11.31%7.45M-10.36%3.94M13.46%17.22M14.17%11.87M29.55%8.4M47.64%4.39M0.76%15.18M-6.42%10.39M-9.52%6.49M-32.69%2.97M
Operating expense -54.23%88.53M-57.06%48.27M-47.59%293.02M-39.15%244.74M-26.72%193.44M-15.66%112.41M-8.32%559.08M-8.48%402.22M-12.55%263.99M-7.48%133.29M
Administration expense -0.19%45.01M6.82%21.03M41.97%103.03M40.19%69.14M39.86%45.09M44.44%19.68M18.38%72.57M11.45%49.32M4.12%32.24M-21.43%13.63M
Financial expense -34.30%-6.41M-119.56%-3.79M19.52%-9.67M17.66%-8.01M30.04%-4.77M56.54%-1.73M50.93%-12.01M50.90%-9.73M39.72%-6.83M30.66%-3.98M
-Interest expense (Financial expense) 58.59%9.74M116.96%4.76M121.51%14.17M152.21%10.25M183.55%6.14M605.76%2.19M1,638.59%6.39M1,120.03%4.07M765.50%2.17M172.20%310.84K
-Interest Income (Financial expense) -17.73%-11.47M-37.87%-5.77M-25.27%-21.95M-24.07%-15.4M-13.58%-9.74M4.72%-4.18M32.04%-17.52M39.46%-12.41M28.06%-8.58M25.20%-4.39M
Research and development 88.02%101.9M136.44%49.09M27.30%143.37M48.23%98.55M36.66%54.2M40.94%20.76M114.30%112.62M82.54%66.48M73.14%39.66M29.84%14.73M
Credit Impairment Loss -96.83%67.18K94.29%2.62M47.84%1.4M29.73%4.5M20.26%2.12M-45.63%1.35M135.67%944.94K18.02%3.47M-42.10%1.76M-12.43%2.48M
Asset Impairment Loss -139.44%-592K-189.50%-720.99K-115.31%-13.98M67.45%-1.82M146.31%1.5M--805.53K-2,387.37%-6.49M-465.16%-5.59M-316.30%-3.24M----
Other net revenue -68.67%9.48M-51.29%9.64M1,863.39%33.3M198.94%30.91M246.58%30.27M509.35%19.79M54.92%-1.89M332.08%10.34M162.68%8.73M9.89%3.25M
Invest income -232.04%-2.22M-58.40%-2.21M42.49%-1.7M-97.08%218.71K-74.43%1.68M-51.37%-1.39M67.24%-2.96M151.85%7.5M216.61%6.56M71.89%-920.11K
-Including: Investment income associates -1,088.72%-4.08M-131.85%-3.53M45.11%-3.3M-125.47%-1.7M-105.45%-343K-24.09%-1.52M62.04%-6.01M193.21%6.66M210.42%6.3M62.42%-1.23M
Asset deal income -597.10%-1.45K--9.47K-1,858.24%-37.66K---11.96K---207.57-----154.71%-1.92K------------
Other revenue -51.04%12.22M-47.79%9.94M618.83%47.62M464.41%28.03M584.03%24.97M1,028.90%19.03M-14.72%6.62M-10.35%4.97M-17.11%3.65M-5.67%1.69M
Operating profit -1.46%136.48M-8.77%53.25M42.49%211.68M23.08%154.51M47.61%138.5M19.89%58.37M-14.71%148.56M5.58%125.54M6.77%93.83M19.78%48.68M
Add:Non operating Income -49.27%162.49K483.98%29.45K-69.68%199.61K28.72%576.92K-25.58%320.28K-36.34%5.04K190.34%658.29K125.98%448.19K132.22%430.38K-95.26%7.92K
Less:Non operating expense -25.57%238.74K342.68%248.69K106.07%4.68M57.49%3.27M10.15%320.76K493.75%56.18K29.77%2.27M39.47%2.08M-52.69%291.2K-94.06%9.46K
Total profit -1.52%136.4M-9.06%53.03M41.00%207.2M22.52%151.82M47.39%138.5M19.79%58.31M-14.89%146.94M5.35%123.91M7.46%93.97M19.76%48.68M
Less:Income tax cost 7.35%11.95M-17.21%5.62M61.35%24.13M4.39%10.93M43.67%11.14M2.81%6.79M-52.25%14.96M-59.43%10.47M-33.10%7.75M62.15%6.6M
Net profit -2.29%124.45M-7.99%47.41M38.70%183.06M24.20%140.89M47.73%127.37M22.46%51.53M-6.61%131.99M23.56%113.44M13.65%86.22M15.04%42.08M
Net profit from continuing operation -2.29%124.45M-7.99%47.41M38.70%183.06M24.20%140.89M47.73%127.37M22.46%51.53M-6.61%131.99M23.56%113.44M13.65%86.22M15.04%42.08M
Less:Minority Profit 143.53%56.35M330.60%19.19M852.70%44.69M502.03%31.1M225.27%23.14M49.01%4.46M-78.16%4.69M-68.92%5.17M-30.81%7.11M-21.16%2.99M
Net profit of parent company owners -34.66%68.1M-40.05%28.22M8.70%138.37M1.40%109.79M31.76%104.23M20.43%47.07M6.22%127.3M44.00%108.28M20.62%79.1M19.23%39.09M
Earning per share
Basic earning per share -34.62%0.34-39.13%0.147.81%0.690.00%0.5430.00%0.52-20.69%0.23-26.44%0.64-30.77%0.54-41.18%0.4-14.71%0.29
Diluted earning per share -34.62%0.34-39.13%0.147.81%0.690.00%0.5430.00%0.52-20.69%0.23-26.44%0.64-30.77%0.54-41.18%0.4-14.71%0.29
Other composite income
Total composite income -2.29%124.45M-7.99%47.41M38.70%183.06M24.20%140.89M47.73%127.37M22.46%51.53M-6.61%131.99M23.56%113.44M13.65%86.22M15.04%42.08M
Total composite income of parent company owners -34.66%68.1M-40.05%28.22M8.70%138.37M1.40%109.79M31.76%104.23M20.43%47.07M6.22%127.3M44.00%108.28M20.62%79.1M19.23%39.09M
Total composite income of minority owners 143.53%56.35M330.60%19.19M852.70%44.69M502.03%31.1M225.27%23.14M49.01%4.46M-78.16%4.69M-68.92%5.17M-30.81%7.11M-21.16%2.99M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data